Leucine metabolism at graded amino acid intakes in children receiving parenteral nutrition.
To assess the response of protein turnover to graded levels of amino acid (AA) intakes, leucine kinetics were determined in six 8- to 16-yr-old patients in a stable nutritional status receiving home parenteral nutrition (PN) for short-bowel syndrome or intestinal pseudo-obstruction syndrome. Although daily energy intake was kept constant at 68.7 +/- 13 kcal/kg lean body mass (LBM) with 25.4 +/- 3.6% lipid, patients were given, for three consecutive 7-day periods, 0.7, 1.5, or 2.5 g AA.kg LBM-1.day-1, with the order of the regimens being randomized. On day 7 of each period, a 4-h infusion of L-[1-13C]leucine was performed during intravenous feeding; plasma [13C]ketoisocaproate and expired 13CO2 enrichments were used to assess whole body leucine turnover (Ra), oxidation rate (Ox), nonoxidative disposal [an estimate of protein synthesis (S)], and leucine derived from protein breakdown (B). Urine collection (24 h) was performed for determination of nitrogen excretion. Results indicate a dose-dependent rise in plasma leucine concentration, Ra, and Ox but no significant change in B. There was a significant increase of S (P = 0.04 analysis of variance) with increased AA intakes as well as net leucine balance (P = 0.02). Results are consistent with improved leucine balance, when leucine intake increases, despite increased leucine oxidation. The net protein gain observed with higher AA intakes may suggest a beneficial effect for children receiving long-term PN.
Goulet
O
O
Service de Gastroentłerologie et Nutrition, Hôpital des Enfants Malades, Institute National de la Santé et de la Recherche Médicale Unité 290, Paris, France.
DePotter
S
S
Salas
J
J
Robert
J J
JJ
Rongier
M
M
Ben Hariz
M
M
Koziet
J
J
Desjeux
J F
JF
Ricour
C
C
Darmaun
D
D
D000293:Adolescent; D000596:Amino Acids / Q000008:administration & dosage* / Q000494:pharmacology; D002245:Carbon Dioxide; D002648:Child; D005260:Female; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000378:metabolism / Q000628:therapy; D007651:Keto Acids / Q000097:blood; D007930:Leucine / Q000097:blood / Q000378:metabolism*; D008297:Male; D009994:Osmolar Concentration; D010084:Oxidation-Reduction; D010288:Parenteral Nutrition; D012119:Respiration; D012778:Short Bowel Syndrome / Q000378:metabolism / Q000628:therapy
D000596:Amino Acids; D007651:Keto Acids; D002245:Carbon Dioxide; C013082:alpha-ketoisocaproic acid; D007930:Leucine